Cargando…
Soluble ST2 as a Potential Biomarker for Risk Assessment of Pulmonary Hypertension in Patients Undergoing TAVR?
Background: Severe aortic valve stenosis (AS) is associated with pulmonary hypertension (PH) and has been shown to limit patient survival. Soluble suppression of tumorigenicity-2 (sST2) is a cardiovascular biomarker that has proven to be an important prognostic marker for survival in patients underg...
Autores principales: | Boxhammer, Elke, Mirna, Moritz, Bäz, Laura, Bacher, Nina, Topf, Albert, Sipos, Brigitte, Franz, Marcus, Kretzschmar, Daniel, Hoppe, Uta C., Lauten, Alexander, Lichtenauer, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954652/ https://www.ncbi.nlm.nih.gov/pubmed/35330140 http://dx.doi.org/10.3390/life12030389 |
Ejemplares similares
-
Comparison of PCWP and LVEDP Measurements in Patients with Severe Aortic Stenosis Undergoing TAVI—Same Same but Different?
por: Boxhammer, Elke, et al.
Publicado: (2022) -
Treatment with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Does Not Affect Outcome in Patients with Acute Myocarditis or Myopericarditis
por: Mirna, Moritz, et al.
Publicado: (2022) -
Tumor necrosis factor alpha—an underestimated risk predictor in patients undergoing transcatheter aortic valve replacement (TAVR)?
por: Mirna, Moritz, et al.
Publicado: (2021) -
Conundrum of Classifying Subtypes of Pulmonary Hypertension—Introducing a Novel Approach to Classify “Borderline” Patients in a Population with Severe Aortic Stenosis Undergoing TAVI
por: Boxhammer, Elke, et al.
Publicado: (2022) -
Severe Aortic Valve Stenosis and Pulmonary Hypertension: A Systematic Review of Non-Invasive Ways of Risk Stratification, Especially in Patients Undergoing Transcatheter Aortic Valve Replacement
por: Boxhammer, Elke, et al.
Publicado: (2022)